Research and Clinical Trials
The Dartmouth-Hitchcock Rheumatology Team participates in the study of new drugs to treat rheumatoid and psoriatic arthritis, as well as other conditions.
Our team also consists of research faculty located at the VA in White River Junction, VT.
A clinical trial is a research study in which people can participate. The purpose of a clinical trial is to study the effectiveness of a treatment, medication, experimental drug, or device.
The following is a list of clinical trials with which the Section of Rheumatology at Dartmouth-Hitchcock Medical Center is currently involved. Talk to your doctor to find out if a clinical trial is right for you.
Rheumatology Clinical Trials
A Long-Term, Open-Label Extension Study Of Tofacitinib (Cp-690,550) For The Treatment Of Psoriatic Arthritis (A3921092)
A Multicenter, Double-blind, Long Term Extension Study to Assess the Safety and Efficacy of Filgotinib in Subjects with Rheumatoid Arthritis
A Phase 2 Study to Investigate the Safety and Efficacy of ABBV-105 Given Alone or in Combination with Upadacitinib (ABBV-599 Combination) with a Background of Conventional Synthetic DMARDs in Subjects with Active Rheumatoid Arthritis with Inadequate Response or Intolerance to Biologic DMARDs
A Phase 3, Randomized, Double-Blind Clinical Trial to Evaluate the Efficacy and Safety of Abatacept SC with Standard Treatment Compared to Standard Treatment Alone in Improving Disease Activity in Adults with Active Idiopathic Inflammatory Myopathy (IIM)
A Phase 3, Randomized, Double-Blind, Study Comparing Upadacitinib (ABT-494) to Placebo and to Adalimumab in Subjects with Active Psoriatic Arthritis Who Have a History of Inadequate Response to at Least One Non-Biologic Disease Modifying Anti-Rheumatic Drug (DMARD)
Treatments Against RA and Effect on FDG PET-CT: The TARGET Trial
Validation of VISTA, a Negative Regulator as a Novel Therapy for Autoimmune Disease